TrialDiabetes, obesity & metabolism2019

First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes.

Ronnie Aronson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.